Quick answer: This laboratory blood screen looks for HIV-1 p24 antigen and antibodies to HIV-1/2. The result must be interpreted against exposure timing, previous tests and any PrEP or PEP use. A reactive screen needs confirmation through the appropriate pathway. QXL must confirm its assay, confidential reporting process and collection instructions before booking in Bengaluru.
Also known as: HIV duo, HIV combo, p24 antigen antibody
What is the HIV 1 & 2 Antigen/Antibody (4th Generation) test used for?#
- A clinician recommends HIV screening after discussion of possible exposure and timing.
- Antenatal or other clinician-directed screening with informed consent.
- Follow-up testing when a previous test was taken during the window period.
Conditions it helps investigate: HIV infection
What does the test measure?#
- HIV-1 p24 antigen: An early viral protein target that can become detectable before antibodies.
- HIV-1/2 antibodies: The immune response to HIV; a combined assay may report a single overall screen result.
How is it tested?#
General principle: a combined immunoassay detects p24 antigen and HIV-1/2 antibodies using enzyme or chemiluminescent signalling. This is a screening assay, not a viral-load test. QXL must confirm its actual fourth-generation kit and current Indian confirmation pathway.
Sample and preparation#
Specimen: Venous blood for serum or assay-approved plasma. The exact tube, required volume and transport conditions must be confirmed by QXL.
- Give the exposure date, previous test dates and any PrEP, PEP or HIV-treatment use to the clinician.
- Routine fasting is generally not required for an isolated HIV screen; follow instructions for any other tests collected together.
- Testing requires consent, confidential result handling and access to counselling.
- After a recent possible exposure, seek prompt clinical advice; do not wait for a screening appointment to discuss prevention.
| Specimen detail | What to confirm |
|---|---|
| Volume | Pending QXL assay/SOP confirmation. |
| Container | Pending QXL assay/SOP confirmation; use the approved collection kit. |
| Stability | Pending QXL validated time/temperature and transport instructions. |
| Rejection | QXL to confirm assay-specific rejection rules; identifier mismatch, unsuitable container or compromised sample requires laboratory review. |
How are the results interpreted?#
- A nonreactive result is interpreted against the date of exposure and assay window. Repeat testing may be needed.
- A reactive screen requires additional testing under the applicable national algorithm; it is not by itself a confirmed diagnosis.
- A combined screen does not measure CD4 cells, treatment response or the quantity of virus.
Reference interval: Use the QXL report’s assay-specific units, reference interval or decision limit. Age, sex, pregnancy, sampling time and clinical context may change interpretation; there is no universal range for this page.
What are the limitations?#
- No HIV test detects infection immediately after exposure.
- PrEP, PEP or other antiretrovirals can affect detection and follow-up planning.
- False-reactive and false-negative results can occur; a clinician resolves discordant findings.
- This adult screening approach is not the diagnostic pathway for infants with perinatal exposure.
How does it compare with other tests?#
- Compared with antibody-only screening, antigen/antibody testing can detect some infections earlier. HIV RNA testing is a separate investigation.
Notes for referring clinicians#
Provide the diagnostic question, prior results and relevant treatment. Confirm the exact assay, specimen SOP and performing laboratory. Discuss results that conflict with the clinical picture before changing management.
Price, report time and home collection#
- Price: Price requires QXL approval; no unverified price is offered.
- Report time: QXL test-specific turnaround pending confirmation; do not infer from another laboratory.
- Home collection: QXL to confirm test-specific eligibility, collection setting and transport before booking. Ask QXL whether eligible home collection in your Bengaluru pincode is free; do not assume every specimen can be collected at home.
- Processing: QXL to confirm in-house versus referral processing and assay/platform.
- Report review: Proposed reviewer assignment only. Medical review, operations verification and sign-off are pending.
Call +91 9964 639 639 or WhatsApp QXL to confirm the current quote, preparation and collection slot.
Frequently asked questions#
What does fourth generation mean?#
The assay combines HIV-1 p24 antigen detection with HIV-1/2 antibody detection, helping detect infection earlier than antibody-only tests.
When can a venous laboratory test detect infection?#
CDC gives a usual window of 18–45 days after exposure for laboratory antigen/antibody testing. This is not an individual guarantee; medication use and exposure timing affect the follow-up plan.
Does a reactive result mean I definitely have HIV?#
A reactive screening result needs confirmation through the appropriate testing pathway. Arrange confidential clinician or counselling follow-up rather than interpreting the screen alone.
Can a negative result exclude a very recent exposure?#
A result obtained too early can be negative despite infection. The clinician will decide whether repeat testing or a different test is appropriate.
Is this the same as HIV RNA PCR?#
No. A nucleic-acid test detects viral genetic material; a fourth-generation screen detects antigen and antibodies. They answer different questions.
Do I need to fast?#
Fasting is generally unnecessary for this test alone. Check the instructions if glucose, lipids or other investigations are collected at the same visit.
Will PEP or PrEP change testing advice?#
Tell the clinician about these medicines before testing. Their use may change which tests and follow-up dates are suitable.
How will my result be reviewed?#
A qualified reviewer should interpret the screen and confirmation plan. The proposed QXL reviewer listed here has not yet approved this page or its operational instructions.
Related test guides#
Sources#
- Clinical principles are supported by the cited textbook sections and current primary guidance; actual QXL kit, specimen volume, stability, price, turnaround and availability remain unverified.
Educational information only; not a diagnosis or a substitute for a doctor’s advice.
Medical & Laboratory Disclaimer
Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.
Dr. Ajitha Pillai
MD (Microbiology), Senior Consultant Microbiologist
QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.

